This study aimed to establish a validated prognostic survival column line chart by analyzing data from patients with colon cancer (CC) in the SEER database... C Li,S Cao,X Sun,... - 《Medicine》 被引量: 0发表: 2023年 Trends in incidence and prognosis for head and neck cancer in the...
Meyerhardt JA. Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions. Semin Oncol. 2011;38(4):533-541. doi:10.1053/j.seminoncol.2011.05.007PubMedGoogle ScholarCrossref 21. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle ...
Your doctor will also do tests to make sure your cancer hasn't come back. Cancer that returns is called a recurrence.Colon canceris most likely to recur in the first 5 years after you're treated. If your cancer does come back, seeing your doctor regularly will help find it early, when...
Currently, little is known about the phenotypes of circulating tumor cells (CTCs), particularly epithelial and mesenchymal phenotypes, and their impact on the prognosis of colorectal cancer (CRC) patients. This study aims to investigate the CTC phenotypes and their prognostic implications in stage III...
Radical surgery followed by adjuvant chemotherapy is still the preferred curative treatment for locally advanced colon cancer; however, the prognosis remains unsatisfactory, with a 5-year overall survival (OS) rate of 52–64%2. Although distant metastasis is decreasing with the development of modern ...
Aspects of survival from colorectal cancer in Denmark. Dan Med J. 2012;59(4):B4428.PubMedGoogle Scholar 12. West NP, Quirke P. Colon cancer surgery: pathological quality control is essential for optimal outcomes. Colorectal Dis. 2018;20(suppl 1):34-35. doi:10.1111/codi...
a Sigmoid colon cancer; Cancer cells do not invade the EL, i.e. pT3ELI − is defined as pT3a. b Sigmoid colon cancer; Cancer cells invade beyond the EL, i.e. pT3ELI + is defined as pT3b. c Ascending colon cancer confined to the posterior wall; EL is not identified ...
Histological characteristics at the invasive front may reflect tumor aggressiveness; specifically, tumor budding (Bd) is an emerging prognostic biomarker in colon cancer (CC). We explored further the significance of Bd for risk stratification by evaluating survival of stage III CC patients included in...
The aim of this study was to evaluate the potential impact of tumor size on the long-term outcome of colon cancer (CC) patients after curative surgery. A total of 782 curatively resected T4a stage CC patients without distant metastasis were enrolled. Patients were categorized into 2 groups acc...
Stage-adjusted 5-year net survival differed significantly between these two subgroups (respectively, 88.2% (95% CI:85.2%-90.5%) and 92.5% (95% CI:90.6%-93.9%)). Conclusion BC survival remained lower in deprived areas in France, despite universal access to cancer care. Intensification of ...